Nasal Mucosal Melanosis may act as a Harbinger of Melanoma: A Case Report by William C. Yao M.D., Kevin S. Emerick M.D., Stefan Kraft M.D., Eric H. Holbrook M.D.

Get full text

SUPPRESSION OF ANTIGEN-INDUCED AIRWAY RESPONSES AND BRONCHIAL HYPERRESPONSIVENESS BY CDP840, A NOVEL STEREOSELECTIVE INHIBITOR OF PHOSPHODIESTERASE TYPE-IV by Hughes, B, Holbrook, M, Allen, R, Owens, R, Perry, M, Warrellow, G, Howat, D, Bloxham, D, Higgs, G

Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19 by Delaunois, A, Abernathy, M, Anderson, WD, Beattie, KA, Chaudhary, KW, Coulot, J, Gryshkova, V, Hebeisen, S, Holbrook, M, Kramer, J, Kuryshev, Y, Leishman, D, Lushbough, I, Passini, E, Redfern, WS, Rodriguez, B, Rossman, EI, Trovato, C, Wu, C, Valentin, J

The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4. by Hughes, B, Howat, D, Lisle, H, Holbrook, M, James, T, Gozzard, N, Blease, K, Hughes, P, Kingaby, R, Warrellow, G, Alexander, R, Head, J, Boyd, E, Eaton, M, Perry, M, Wales, M, Smith, B, Owens, R, Catterall, C, Lumb, S, Russell, A, Allen, R, Merriman, M, Bloxham, D, Higgs, G

Skull Base Erosion and Associated Complications in Sphenoid Sinus Fungal Balls by Josh C. Meier M.D., George A. Scangas M.D., Aaron K. Remenschneider M.D., M.P.H., Peter Sadow M.D., Ph.D., Kyle Chambers M.D., Matt Dedmon M.D., Ph.D., Derrick T. Lin M.D., Eric H. Holbrook M.D., Ralph Metson M.D., Stacey T. Gray M.D.

Get full text

General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA in silico strategy by Li, Z, Mirams, GR, Yoshinaga, T, Ridder, BJ, Han, X, Chen, JE, Stockbridge, NL, Wisialowski, TA, Damiano, B, Severi, S, Morissette, P, Kowey, PR, Holbrook, M, Smith, G, Rasmusson, RL, Liu, M, Song, Z, Qu, Z, Leishman, DJ, Steidl‐Nichols, J, Rodriguez, B, Bueno‐Orovio, A, Zhou, X, Passini, E, Edwards, AG

Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence by Andrews, MD, Fish, P, Blagg, J, Brabham, T, Brennan, P, Bridgeland, A, Brown, A, Bungay, P, Conlon, K, Edmunds, N, af Forselles, K, Gibbons, C, Green, M, Hanton, G, Holbrook, M, Jessiman, A, McIntosh, K, McMurray, G, Nichols, C, Root, J, Storer, R, Sutton, MR, Ward, R, Westbrook, D, Whitlock, G